Cynthia Smith
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Akebia Therapeutics Inc., 3 years.
Akebia Therapeutics Inc.
Director
Protara Therapeutics Inc.
Director
Agios Pharmaceuticals Inc.
Director
Spero Therapeutics Inc.
Director
Tvardi Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Spero Therapeutics Inc. | Grant or award | +10,000 | — | — |
| Jun 18, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +2,816 | — | — |
| Jun 17, 2026 | Akebia Therapeutics Inc. | Grant or award | +35,700 | — | — |
| Aug 11, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,302 | — | — |
| Jun 20, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,120 | — | — |
| Jun 12, 2025 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Jun 10, 2025 | Akebia Therapeutics Inc. | Grant or award | +35,700 | — | — |
| Aug 11, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +2,302 | — | — |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +3,388 | — | — |
| Jun 6, 2024 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
| May 29, 2024 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Oct 5, 2023 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Aug 11, 2023 | Agios Pharmaceuticals Inc. | Option exercise | +2,302 | — | — |
| Jun 6, 2023 | Akebia Therapeutics Inc. | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.